A scoping review of the patient experience with wearable technology.

Objective: This scoping review explores patients' experience with wearable technology. Its aims are to: (a) examine studies that contain empirical findings related to patients' experience with wearables; (b) compare these findings within and across studies; and (c) identify areas in need of greater understanding.

Methods: A Preferred Reporting Items for Scoping Review (PRISMA) guided approach was followed.

Validation of the Portuguese Version of the Modified Harris Hip Score Questionnaire - HHSmBr.

 To validate the Portuguese version of the evaluation instrument modified Harris Hip Score.  The modified Harris Hip Score went through a validation process for the Portuguese language. We tested the measurement properties of the Brazilian Portuguese version of the modified Harris Hip Score (HHSmBr) on 100 patients (63% females and 37% males) with different hip conditions.

Analysis of topical conjunctival microbiotic cultures in patients treated with intravitreal injections using antibiotic prophylaxis with 0.3% ofloxacin eye drops.

Background: Intravitreal injections, a relatively recent treatment in ophthalmology, is being adopted rapidly worldwide and becoming one of the most common therapies in the field. Numerous complications are associated with this treatment, ranging from minor inflammatory ailments to endophthalmitis. We analyzed the conjunctival flora of patients treated with intravitreal injections and topical antibiotics.

Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppression.

The maintenance of stable allograft status in the absence of immunosuppression, known as operational tolerance, can be achieved in a small proportion of liver transplant recipients, but we lack reliable tools to predict its spontaneous development. We conducted a prospective, multi-center, biomarker-strategy design, immunosuppression withdrawal clinical trial to determine the utility of a predictive biomarker of operational tolerance. The biomarker test, originally identified in a patient cohort with high operational tolerance prevalence, consisted of a 5-gene transcriptional signature measured in liver tissue collected before initiating immunosuppression weaning.